Medical Policies
Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.
Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.
Medical Policies table
| ID | Title | Review | Description | Access |
|---|---|---|---|---|
| 11.003.053 | Whole Exome And Whole Genome Sequencing For Diagnosis Of Genetic Disorders | Feb 2026 | Whole exome sequencing (wes) sequences the portion of the genome that contains protein-coding dna, while... | View |
| 11.003.056 | Genetic Testing For A Thalassemia | Jul 2025 | Alpha-thalassemia represents a group of clinical syndromes of varying severity characterized by hemolytic... | View |
| 11.003.057 | Genetic Testing For Fanconi Anemia | Jan 2026 | Fanconi anemia (fa) is an inherited disorder characterized by congenital abnormalities, bone marrow failure,... | View |
| 11.003.059 | Genetic Testing For Hereditary Pancreatitis | Mar 2026 | ... | View |
| 11.003.060 | Genetic Testing For Flt3, Npm1, And Cebpa Variants In Cytogenetically Normal Acute Myeloid Leukemia | Feb 2026 | Treatment of acute myeloid leukemia (aml) is based on risk stratification, primarily related to age and tumor... | View |
| 11.003.061 | Genotipado de Nucleótido único 9p21-polimorfismos de Predecir el Riesgo | Oct 2016 | ... | View |
| 11.003.062 | General Approach To Genetic Testing | Jan 2026 | Commercially available genetic tests can perform a host of functions, such as providing a guided intervention... | View |
| 11.003.063 | Bcr-Abl1 Testing In Chronic Myelogenous Leukjemia And Acute Lymphoblastic Leukemia | Nov 2025 | In the treatment of philadelphia chromosome-positive leukemias, various nucleic acid-based laboratory methods... | View |
| 11.003.064 | Genetic Cancer Susceptibility Panels Using Next Generation Sequencing | Feb 2026 | Commercially available cancer susceptibility gene panels can test for multiple variants associated with a... | View |
| 11.003.066 | Genetic Testing For Duchenne And Becker Muscular Dystrophy | Apr 2026 | Variants in the duchenne muscular dystrophy (dmd) gene, which encodes the protein dystrophin, may result in a... | View |
| 11.003.067 | Genotype-Guided Warfarin Dosing | Jul 2025 | Using information about an individual's genotype may help in guiding warfarin dosing and could reduce... | View |
| 11.003.068 | Genetic Testing For The Diagnosis Of Inherited Peripheral Neuropathies | Feb 2026 | The inherited peripheral neuropathies are a heterogeneous group of diseases that may be inherited in an... | View |
| 11.003.069 | Analysis Of Mgmt Promoter Methylation In Malignant Gliomas | Jun 2019 | Testing for o6-methylguanine-dna methyltransferase (mgmt) gene promoter methylation has been proposed as a... | View |
| 11.003.070 | Preimplantation Genetic Testing | Sep 2025 | Preimplantation genetic testing involves the analysis of biopsied cells as part of an assisted reproductive... | View |
| 11.003.072 | Genetic Testing For Marfan Syndrome, Thoracic Aortic Aneurysms And Dissections, And Related Disorders | Mar 2026 | Marfan syndrome (mfs) is a systemic connective tissue disease (ctd) with a high degree of clinical... | View |
| 11.003.073 | Laboratory And Genetic Testing For Use Of 5-Fluorouracil In Patients With Cancer | Apr 2025 | Variability in systemic exposure to 5-fluorouracil chemotherapy is thought to directly impact 5-fluorouracil... | View |
| 11.003.075 | Proteomic Testing For Targeted Therapy In Non-Small-Cell Lung Cancer | Dec 2025 | Proteomic testing has been proposed as a way to predict survival outcomes, as well as the response to and... | View |
| 11.003.076 | Multibiomarker Disease Activity Blood Test For Rheumatoid Arthritis | Jul 2025 | Assessment of disease activity in rheumatoid arthritis (ra) is an important component of management with a... | View |
| 11.003.077 | Los ensayos de varios analitos con el análisis algorítmico para predecir el ries | Oct 2016 | ... | View |
| 11.003.078 | Noninvasive Prenatal Screening For Fetal Aneuploidies And Microdeletions Using Cell-Free Fetal Dna | Apr 2026 | ... | View |
